Opioid Use Disorder Market Insights, Epidemiology and Forecasts, 2032: Treatment, Drug Class, Therapies, Outlook, Pipeline Activities, Treatment Programs
September 29, 2023 10:13 ET
|
Research and Markets
Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Opioid Use Disorder - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The...
Global Opioid Use Disorder Market Insights 2023-2032: Epidemiology, Drugs, Pipeline, Reimbursement, Competitors
June 23, 2023 04:08 ET
|
Research and Markets
Dublin, June 23, 2023 (GLOBE NEWSWIRE) -- The "Opioid Use Disorder - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This...
BioCorRx Selects Covance for Non-Clinical Studies, Announces the Addition of Dr. Bal S. Brar to its Drug Development Team, Plans Pre-IND Meeting with FDA
November 28, 2016 06:00 ET
|
BioCorRx
ANAHEIM, CA, Nov. 28, 2016 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTC PINK: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions,...
Assisted Recovery Centers of America Offers New Treatment Options for Alcohol Dependence
December 11, 2006 15:28 ET
|
Assisted Recovery Centers of America
ST. LOUIS, Dec. 11, 2006 (PRIME NEWSWIRE) -- As a leader in the field, Assisted Recovery Centers of America (ARCA) continues to offer innovative treatment options as part of their comprehensive...